Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatitis c virus replicons and replicon enhanced cells

Hepatitis c virus replicons and replicon enhanced cells

US Patent 8198426 · Granted Jun 12, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oxalamido-substituted tricyclic inhibitors of hepatitis b virus2025
Spirocyclic inhibitors of hepatitis B virus2025
Tricyclic inhibitors of Hepatitis B virus2022
Compounds for use in the treatment of kinetoplastid infection2020
Compounds for use in the treatment of parasitic diseases2016
Modulators of HCV replication2011
Method for identifying a HCV RNA-dependent RNA polymerase inhibitor2008
In vitro mass production of human erythroid cells from the blood of normal donor2005
Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment 2003
Method for producing in vitro the RNA-dependent RNA polymerase and terminal nucl2002
Methodology to produce, and purify and assay polypeptides with the proteolytic a2001
DNA encoding human IL-6 receptor antagonist and protein encoded thereby1999